ESCRS - PO575 - Results Of Implantation Of The Edof Vivity And Vivity Toric Iol In Patients With Hyperopia And Presbyopia

Results Of Implantation Of The Edof Vivity And Vivity Toric Iol In Patients With Hyperopia And Presbyopia

Published 2024 - 42nd Congress of the ESCRS

Reference: PO575 | Type: Free paper | DOI: 10.82333/nz8z-jj84

Authors: Elena Likhorad* 1 , Pavel Beliakouski 1 , Mikalai Pazniak 1 , Aleh Pazniak 1 , Aksana Shiriaeva 1 , Kiryl Zhukau 1

1Microsurgery,Eye Microsurgery Center VOKA,Minsk,Belarus

Purpose

Analysis of the results of refractive lensectomy (RLE) with the EDOF Vivity and Vivity Toric IOL (Alcon, USA) implantation in patients with hyperopia and presbyopia.

Setting

Eye Microsurgery Сenter VOKA, Minsk, Belarus

Methods

Retrospective analysis of 68 cases of a RLE with implantation of Vivity and Vivity Toric IOL (Alcon, USA) in patients with hyperopia, presbyopia at the age of 57.09 ± 6.68 years.

Uncorrected visual acuity (VA) before surgery 0.33 ± 0.20, best corrected VA 0.94±0.09, refraction sph 1.90 ± 0.76 min, 0.25 D / max 4.75 D; cyl 1.06 ± 0.64, min 0.25 D / max 4.0 D; corneal astigmatism: 1.07 ± 0.57, min 0.16 D / max 4.30 D; axial length 23.15 ± 0.70 mm, min 21.76 mm / max 24.57 mm. DFT015-DFT315, DFT515 were implanted.

Results

The following results were obtained in 3 months after the surgery: uncorrected distant VA 0.95 ± 0.06, intermideate VA (60 - 70 cm) 0.53 ± 0.06, functional near VA
(45 cm) 0.55 ± 0.11refraction sph 0.21 ± 0.36; cyl -0,70± 0.73.

Conclusions

An analysis of the results of refractive lensectomy with the EDOF Vivity and Vivity Toric IOL (Alcon, USA) implantation in patients with hyperopia and presbyopia in 3 months after
surgery showed an improvement in visual acuity in far, middle and near distances and stabilization of the obtained refractive effect.